In accordance with privacy legislation, Kedrion S.p.A., controller of the data collected through this website, hereby informs the user that this website does not use profiling cookies to send advertising messages in line with the preferences expressed when browsing the web. This website installs third party cookies. By continuing to browse, including by scrolling down and clicking on website elements, the user agrees to the company’s cookies policy.
For more information, also as regards the technical cookies used by the website and to object to the use of individual cookies, reference should be made to the complete cookies disclosure.
You are now leaving Kedrion Corporate site. Medical information including licensed uses may be different outside of the EU countries.
NO
YES
HIGHLIGHTS
EVENTS
Kedrion Biopharma celebrates World Hemophilia Day 2018
Support for patients with coagulation disorders worldwide is confirmed
read moreEVENTS
50-Year Anniversary of a Maternal Health Breakthrough
Kedrion Biopharma supports session on Anti-D achievements and challenges at FIGO Congress in Dubai
read moreCORPORATE
Kedrion Biopharma runner up at the Premio Equita for the bond issued in July 2017
The prize is awarded to the companies that made the best use of the capital markets
read more-
CORPORATE - 19-04-2017
Kedrion Biopharma signs agreement with European Hemophilia Consortium (EHC)
The agreement aims to improve patient access to coagulation disorders treatments in Europe
read more -
EVENTS - 14-04-2017
Kedrion Biopharma initiatives for World Hemophilia Day 2017
The goal is to provide wider access to plasma-derived therapies for coagulation disorders the world over
read more -
CORPORATE - 24-03-2017
New company AO Kirov Plasma established in Russia
It’s a joint venture between Kedrion Biopharma, Nacimbio and Pharmastandard
read more -
PLASMA & BIOTHERAPIES - 22-03-2017
Article by Prof. Farrugia and Daniela Scaramuccia published on “Biologicals”
International medical journal hosts review of contract plasma fractionation dynamics
read more
Pages
For more information please contact: pressoffice@kedrion.com
Where 